Contact this trialFirst, we need to learn more about you.
Checkpoint Inhibitor
Nivolumab + Relatlimab vs Pembrolizumab with Chemotherapy for Lung Cancer
Recruiting2 awardsPhase 3
Tucson, Arizona
This trial aims to compare how well two different drug combinations (Nivolumab and Relatlimab with chemotherapy versus Pembrolizumab with chemotherapy) work in treating participants with advanced or recurrent
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.